Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citizens Financial Group | 231k | $241k | 100% | Sep 2025 |
|
| Morgan Stanley | 219k | $245k | 100% | Jun 2025 |
|
| Renaissance Technologies | 157k | $164k | -7% | Sep 2025 |
|
| Citadel Advisors | 69k | $72k | -13% | Sep 2025 |
|
| Susquehanna International | 55k | $57k | 100% | Sep 2025 |
|
| XTX Topco | 43k | $44k | 100% | Sep 2025 |
|
| Two Sigma Securities | 34k | $36k | 100% | Sep 2025 |
|
| Sigma Investment Counselors | 28k | $29k | 0% | Sep 2025 |
|
| Jane Street | 22k | $22k | -65% | Sep 2025 |
|
| Hrt Financial | 19k | $19k | 100% | Sep 2025 |
|
| Prosperity Consulting Group | 18k | $18k | 100% | Sep 2025 |
|
| Neuberger Berman Group | 11k | $11k | 0% | Sep 2025 |
|
| Two Sigma Investments | 11k | $11k | 100% | Sep 2025 |
|
| SkyView Investment Advisors | 10k | $12k | 0% | Jun 2025 |
|
| Wells Fargo & Company | 9.2k | $9.6k | 0% | Sep 2025 |
|
| Group One Trading | 7.0k | $7.3k | 0% | Sep 2025 |
|
| Signature | 5.0k | $5.2k | 0% | Sep 2025 |
|
| UBS Group | 4.0k | $4.2k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 2.5k | $2.6k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 2.1k | $2.2k | -70% | Sep 2025 |
|
| SRS Capital Advisors | 1.0k | $1.1k | 0% | Sep 2025 |
|
| BFSG | 1.0k | $1.0k | 0% | Sep 2025 |
|
| Activest Wealth Management | 1.0k | $1.0k | 0% | Sep 2025 |
|
| Spire Wealth Management | 500.00 | $520.000000 | 0% | Sep 2025 |
|
| Red Tortoise | 150.00 | $156.000000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 100.00 | $104.000000 | -95% | Sep 2025 |
|
| Advisory Services Network | 43.00 | $44.999500 | 100% | Sep 2025 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Sep 2025 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 612k | $686k |
| Raymond James Financial | Jun 2025 | 57.00 | $63.999600 |